Epidemiologic Features of Vulvovaginal Candidiasis among Reproductive-Age Women in India

Table 1

Diagnostic criteria and treatment given for laboratory- and clinically-diagnosed gynecological conditions, Mysore, India 2005-2006.

Diagnosis	Diagnostic criteria	Laboratory device	Treatment
Candida infection	Positive culture	InTray Colorex Yeast, BioMed Diagnostics, White City, OR, USA	None
Vulvovaginal candidiasis	Positive culture for Candida infection and one clinical sign (vaginal erythema or discharge) and one reported symptom (vaginal pruritis or discharge)		150 mg oral fluconazole, single dose
Trichomonas vaginalis	Positive culture or positive saline wet mount microscopy	InPouch, BioMed Diagnostics, White City, OR, USA	2 g oral metronidazole, single dose
Bacterial vaginosis, laboratory	Score of 7–10 on Nugent criteria from Gram stain		None
Intermediate flora, laboratory	Score of 4–6 on Nugent criteria from Gram stain		None
Abnormal flora, laboratory	Score of 4–10 on Nugent criteria from Gram stain [21]		None
Bacterial vaginosis, clinical	Positive on at least three of four Amsel criteria (elevated pH, positive whiff test, clue cells observed, discharge observed) [22]		400 mg oral metronidazole, bid for 7 days
Herpes simplex virus type 2	Index value >1.1 on ELISA test of serum	Focus Technologies, Cypress, CA, USA	Acyclovir 400 mg tid for 7–10 days